India’s pharma exports rose 11 per cent to $19.2 billion in 2018-19, accounting for about six per cent of the country’s total exports of $331 billion in this fiscal. (Source: Pharmexcil report). An IBEF Report highlights,”double-digit growth has returned to pharma exports after three years of flat-to-marginal growth’ This could be a sign that recent upheavals notwithstanding, our pharma sector is slowly regaining its growth momentum. But, as India Pharma Inc’s aspirations become bolder, its progress will be underpinned by the ability to sustain performance and move up the value chain. However, this will require some tough decisions today to capitalise on the potential opportunities in important markets.
Therefore, the second edition of Goa Pharma Summit, organised by Express Pharma, will focus on the theme ‘Capturing growth in a complex landscape,’. This year, experts and veterans of the industry will examine the new global reality and share learnings to customise their strategies and business models for dealing with increasing volatility and complexity in various business environments and fuelling sustainable, long-term growth.
Moreover, it will also look at establishing the role Goa can play in cementing India Pharma Inc’s dominance on the world stage, as a premier, export-oriented, pharma hub in India. The Summit will seek actionable insights to reinvigorate Goa’s pharma sector and leverage its capabilities to turn India into a global supply destination by finding answers to pertinent questions such as:
Thus, there is lot in store for the delegates at Goa Pharma Summit 2019.